[ad_1]

51 CBD FOR ACNECannabidiol as a Treatment for Acne?1 CBD FOR ACNECannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes1 CBD FOR ACNEThe endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities1 CBD FOR ACNEEndocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling1 CBD FOR ACNEEndocannabinoid signaling and epidermal differentiation62 CBD FOR ADD / ADHDSearching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders2 CBD FOR ADD / ADHDCannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats2 CBD FOR ADD / ADHDSubtypes of Attention Deficit — Hyperactivity Disorder (ADHD) and cannabis use2 CBD FOR ADD / ADHDChildhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students2 CBD FOR ADD / ADHDOral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: A case report2 CBD FOR ADD / ADHDFitness to drive in spite (because) of THC103 CBD FOR ADDICTIONCannabidiol reduces cigarette consumption in tobacco smokers3 CBD FOR ADDICTIONCannabidiol inhibits the reward-facilitating effect of morphine3 CBD FOR ADDICTIONCannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances3 CBD FOR ADDICTIONDifferential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats3 CBD FOR ADDICTIONImpact of Cannabis Use during Stabilization on Methadone Maintenance Treatment3 CBD FOR ADDICTIONMedical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-20103 CBD FOR ADDICTIONDysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents3 CBD FOR ADDICTIONComparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity3 CBD FOR ADDICTIONTransdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder3 CBD FOR ADDICTIONCannabidiol for the treatment of cannabis withdrawal syndrome44 CBD FOR ALS Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials4 CBD FOR ALSALS: delayed disease progression in mice by treatment with a cannabinoid4 CBD FOR ALSThe (Endo)Cannabinoid System in Multiple Sclerosis and ALS4 CBD FOR ALSSurvey of cannabis use in patients with ALS165 CBD FOR ALZHEIMERSThe therapeutic potential of the endocannabinoid system for Alzheimer’s disease5 CBD FOR ALZHEIMERSEndocannabinoid signalling in Alzheimer’s disease5 CBD FOR ALZHEIMERSA molecular link between the active component of marijuana and Alzheimer’s disease pathology5 CBD FOR ALZHEIMERSNeuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells5 CBD FOR ALZHEIMERSThe Potential Therapeutic Effects of THC on Alzheimer’s Disease5 CBD FOR ALZHEIMERSThe Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease5 CBD FOR ALZHEIMERSCannabinoids for the treatment of dementia5 CBD FOR ALZHEIMERSCannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression5 CBD FOR ALZHEIMERSCannabidiol: A promising drug for neurodegenerative disorders?5 CBD FOR ALZHEIMERSCannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition5 CBD FOR ALZHEIMERSThe role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses5 CBD FOR ALZHEIMERSThe role of phytochemicals in the treatment and prevention of dementia5 CBD FOR ALZHEIMERSCannabinoids for the treatment of dementia5 CBD FOR ALZHEIMERSCannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement5 CBD FOR ALZHEIMERSCannabinoids for treatment of Alzheimer’s disease: moving toward the clinic5 CBD FOR ALZHEIMERSCan Marijuana Prevent Alzheimer’s?46 CBD FOR ANOREXIALeptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa6 CBD FOR ANOREXIAThe role of the endocannabinoid system in eating disorders: Neurochemical and behavioural preclinical evidence6 CBD FOR ANOREXIACancer cachexia and cannabinoids6 CBD FOR ANOREXIABrain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa97 CBD FOR ANXIETYCannabidiol, a Cannabis sativa constituent, as an anxiolytic drug7 CBD FOR ANXIETYAntidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa7 CBD FOR ANXIETYCannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients7 CBD FOR ANXIETYNeural basis of anxiolytic effects of cannabidiol ( CBD) in generalized social anxiety disorder7 CBD FOR ANXIETYCentral anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation7 CBD FOR ANXIETYEffects of cannabidiol ( CBD) on regional cerebral blood flow7 CBD FOR ANXIETYThe anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors7 CBD FOR ANXIETYThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system7 CBD FOR ANXIETYPlant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence48 CBD FOR ATHEROSCLEROSISThe role of the endocannabinoid system in atherosclerosis8 CBD FOR ATHEROSCLEROSISCannabinoid receptors in atherosclerosis8 CBD FOR ATHEROSCLEROSISThe potential use of cannabidiol in the therapy of metabolic syndrome8 CBD FOR ATHEROSCLEROSISLow dose oral cannabinoid therapy reduces progression of atherosclerosis in mice49 CBD FOR ARTHRITISPreliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis9 CBD FOR ARTHRITISThe nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis9 CBD FOR ARTHRITISThe abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR559 CBD FOR ARTHRITISArthritis and cannabinoids510 CBD FOR ASTHMAThe role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke10 CBD FOR ASTHMAAllergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma10 CBD FOR ASTHMAActivation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs10 CBD FOR ASTHMAEndogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways10 CBD FOR ASTHMABronchodilator effect of delta1-tetrahydrocannabinol511 CBD FOR AUTISMMutations found in individuals with autism interfere with endocannabinoid signaling in the brain11 CBD FOR AUTISMCannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders11 CBD FOR AUTISMA novel approach to the symptomatic treatment of autism11 CBD FOR AUTISMConsequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders11 CBD FOR AUTISMTargeting the endocannabinoid system in the treatment of fragile X syndrome512 CBD FOR BIPOLAR AFFECTIVE DISORDERCannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential12 CBD FOR BIPOLAR AFFECTIVE DISORDERCannabidiol was ineffective for manic episode of bipolar affective disorder12 CBD FOR BIPOLAR AFFECTIVE DISORDEREffects of Co-occurring Cannabis Use Disorders on the Course of Bipolar Disorder After a First Hospitalization for Mania12 CBD FOR BIPOLAR AFFECTIVE DISORDERDoes Cannabis Use Affect Treatment Outcome in Bipolar Disorder?: A Longitudinal Analysis12 CBD FOR BIPOLAR AFFECTIVE DISORDERThe Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical Research513 CBD FOR CANCER – GENERALCannabidiol as potential anticancer drug13 CBD FOR CANCER – GENERALCannabidiol inhibits angiogenesis by multiple mechanisms13 CBD FOR CANCER – GENERALThe inhibitory effects of cannabidiol on systemic malignant tumors13 CBD FOR CANCER – GENERALCannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-113 CBD FOR CANCER – GENERAL Marijuana fights cancer and helps manage side effects414 CBD FOR CANCER – LUNGCannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1C14 CBD FOR CANCER – LUNGCOX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells14 CBD FOR CANCER – LUNGDecrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells14 CBD FOR CANCER – LUNGMedia ignored expert’s shocking findings that marijuana helps prevent lung cancer515 CBD FOR CANCER – PROSTATE/COLONTowards the use of non-psychoactive cannabinoids for prostate cancer15 CBD FOR CANCER – PROSTATE/COLONIn Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines15 CBD FOR CANCER – PROSTATE/COLONInduction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent15 CBD FOR CANCER – PROSTATE/COLONChemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer15 CBD FOR CANCER – PROSTATE/COLONInhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol516 CBD FOR CANCER – BREASTAntitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma16 CBD FOR CANCER – BREASTCannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy16 CBD FOR CANCER – BREASTPathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis16 CBD FOR CANCER – BREASTCannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells16 CBD FOR CANCER – BREASTCannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration817 CBD FOR CANCER – BRAINCannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival17 CBD FOR CANCER – BRAINAntitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines(PubMed)17 CBD FOR CANCER – BRAINSystematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas17 CBD FOR CANCER – BRAINCannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism17 CBD FOR CANCER – BRAINId-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target17 CBD FOR CANCER – BRAINTriggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents17 CBD FOR CANCER – BRAINCannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect17 CBD FOR CANCER – BRAINLocal delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme418 CBD FOR CANCER – LEUKEMIACannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression18 CBD FOR CANCER – LEUKEMIACannabidiol-Induced Apoptosis in Human Leukemia Cells18 CBD FOR CANCER – LEUKEMIACannabidiol Reduces Leukemic Cell Size – But Is It Important?18 CBD FOR CANCER – LEUKEMIATargeting cannabinoid receptors to treat leukemia419 CBD FOR CANCER – SKINAnticancer activity of anandamide in human cutaneous melanoma cells19 CBD FOR CANCER – SKINCannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpes virus-infected endothelium (PubMed)19 CBD FOR CANCER – SKINCannabinoid receptors as novel targets for the treatment of melanoma19 CBD FOR CANCER – SKINThe Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development420 CBD FOR CANCER – ENDOCRINEEndocannabinoids in endocrine and related tumours20 CBD FOR CANCER – ENDOCRINEA comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells20 CBD FOR CANCER – ENDOCRINECannabinoids in pancreatic cancer: Correlation with survival and pain20 CBD FOR CANCER – ENDOCRINECannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma421 CBD FOR CANCER – BLADDERTRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer21 CBD FOR CANCER – BLADDERAssociation Between Cannabis Use and the Risk of Bladder Cancer21 CBD FOR CANCER – BLADDERInhibitory Effect of Standardized Cannabis sativaExtract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility21 CBD FOR CANCER – BLADDERBladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism422 CBD FOR CANCER – PAIN RELIEFMulticenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain22 CBD FOR CANCER – PAIN RELIEFNabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial22 CBD FOR CANCER – PAIN RELIEF Marijuana extract helps prevent chemo pain22 CBD FOR CANCER – PAIN RELIEFAn Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/ CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics1023 CBD FOR CROHNS & COLITISCannabidiol in inflammatory bowel diseases: a brief overview23 CBD FOR CROHNS & COLITIS Cannabis finds its way into treatment of Crohn’s disease23 CBD FOR CROHNS & COLITISCannabidiol reduces intestinal inflammation through the control of neuroimmune axis23 CBD FOR CROHNS & COLITISCannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis23 CBD FOR CROHNS & COLITISThe effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis23 CBD FOR CROHNS & COLITISTopical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice23 CBD FOR CROHNS & COLITISCannabinoids and the gut: New developments and emerging concepts23 CBD FOR CROHNS & COLITISEndocannabinoids and the gastrointestinal tract23 CBD FOR CROHNS & COLITISCannabinoids and gastrointestinal motility: Animal and human studies23 CBD FOR CROHNS & COLITISHergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis1124 CBD FOR DEPRESSIONEndocannabinoid system dysfunction in mood and related disorders24 CBD FOR DEPRESSIONAntidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa24 CBD FOR DEPRESSIONThe endocannabinoid system and the treatment of mood and anxiety disorders24 CBD FOR DEPRESSIONEndocannabinoid signaling in the etiology and treatment of major depressive illness24 CBD FOR DEPRESSIONAntidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors24 CBD FOR DEPRESSIONPutative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants24 CBD FOR DEPRESSIONAntidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa24 CBD FOR DEPRESSIONCirculating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress24 CBD FOR DEPRESSIONSerum contents of endocannabinoids are correlated with blood pressure in depressed women24 CBD FOR DEPRESSIONThe therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants24 CBD FOR DEPRESSIONAntidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures2125 CBD FOR ENDOCRINE DISORDERSEndocannabinoid system participates in neuroendocrine control of homeostasis25 CBD FOR ENDOCRINE DISORDERSThe emerging role of the endocannabinoid system in endocrine regulation and energy balance25 CBD FOR ENDOCRINE DISORDERSEndocannabinoids in endocrine and related tumours25 CBD FOR ENDOCRINE DISORDERSRole of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas25 CBD FOR ENDOCRINE DISORDERSThe role of the endocannabinoid system in the neuroendocrine regulation of energy balance25 CBD FOR ENDOCRINE DISORDERS CBD for children with Dravet’s and intractable seizures25 CBD FOR ENDOCRINE DISORDERSReport of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy25 CBD FOR ENDOCRINE DISORDERSMedicinal marijuana stops seizures, brings hope to a little girl25 CBD FOR ENDOCRINE DISORDERSCannabinoids for epilepsy25 CBD FOR ENDOCRINE DISORDERS Cannabis, cannabidiol, and epilepsy – From receptors to clinical response25 CBD FOR ENDOCRINE DISORDERSThe non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol ( CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability25 CBD FOR ENDOCRINE DISORDERSChronic administration of cannabidiol to healthy volunteers and epileptic patients25 CBD FOR ENDOCRINE DISORDERSEndocannabinoid system protects against cryptogenic seizures25 CBD FOR ENDOCRINE DISORDERSSeizing an opportunity for the endocannabinoid system25 CBD FOR ENDOCRINE DISORDERSCannabidiol: promise and pitfalls25 CBD FOR ENDOCRINE DISORDERSCannabidivarin (CBDV) suppressespentylenetetrazole (PTZ)-inducedincreases in epilepsy-related gene expression25 CBD FOR ENDOCRINE DISORDERSCannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures25 CBD FOR ENDOCRINE DISORDERSCannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo25 CBD FOR ENDOCRINE DISORDERSHypnotic and antiepileptic effects of cannabidiol25 CBD FOR ENDOCRINE DISORDERSThe cannabinoids as potential antiepileptics25 CBD FOR ENDOCRINE DISORDERSCannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats526 CBD FOR FIBROMYALGIAClinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?26 CBD FOR FIBROMYALGIA Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life26 CBD FOR FIBROMYALGIAAssociation of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia26 CBD FOR FIBROMYALGIACannabinoids for fibromyalgia26 CBD FOR FIBROMYALGIAMedical Cannabis for the Treatment of Fibromyalgia427 CBD FOR GLAUCOMANeuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite27 CBD FOR GLAUCOMACannabinoids and glaucoma27 CBD FOR GLAUCOMAThe treatment of glaucoma using a non-psychoactive preparation of Cannabis sativa27 CBD FOR GLAUCOMACannabinoids for treatment of glaucoma728 CBD FOR HEART DISEASEIs the cardiovascular system a therapeutic target for cannabidiol?28 CBD FOR HEART DISEASEAcute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion28 CBD FOR HEART DISEASECannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy28 CBD FOR HEART DISEASEThe Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias: The Role of Adenosine A1 Receptors28 CBD FOR HEART DISEASECannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury28 CBD FOR HEART DISEASEEndocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension28 CBD FOR HEART DISEASEOleamide: A fatty acid amide signaling molecule in the cardiovascular system?629 CBD FOR HUNTINGTONS DISEASENeuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease29 CBD FOR HUNTINGTONS DISEASECannabinoids: Novel medicines for the treatment of Huntington’s disease29 CBD FOR HUNTINGTONS DISEASESativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB(1) and CB(2) receptors29 CBD FOR HUNTINGTONS DISEASEControlled clinical trial of cannabidiol in Huntington’s disease29 CBD FOR HUNTINGTONS DISEASEProspects for cannabinoid therapies in basal ganglia disorders29 CBD FOR HUNTINGTONS DISEASENeuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice1330 CBD FOR INFLAMMATIONCannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress30 CBD FOR INFLAMMATIONThe endocannabinoid system: an emerging key player in inflammation30 CBD FOR INFLAMMATIONAnti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice30 CBD FOR INFLAMMATIONCannabinoids, endocannabinoids, and related analogs in inflammation30 CBD FOR INFLAMMATIONCannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor30 CBD FOR INFLAMMATIONCannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors30 CBD FOR INFLAMMATIONCannabidiol reduces intestinal inflammation through the control of neuroimmune axis30 CBD FOR INFLAMMATIONDiabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation30 CBD FOR INFLAMMATIONCannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement30 CBD FOR INFLAMMATIONCannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption30 CBD FOR INFLAMMATIONVanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation30 CBD FOR INFLAMMATIONCannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death30 CBD FOR INFLAMMATIONCannabinoids in clinical practice931 CBD FOR IRRITABLE BOWEL SYNDROMECannabidiol in inflammatory bowel diseases: A brief overview31 CBD FOR IRRITABLE BOWEL SYNDROMECannabidiol reduces intestinal inflammation through the control of neuroimmune axis31 CBD FOR IRRITABLE BOWEL SYNDROMEClinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?31 CBD FOR IRRITABLE BOWEL SYNDROMECannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation31 CBD FOR IRRITABLE BOWEL SYNDROMETherapeutic potential of cannabinoid-based drugs31 CBD FOR IRRITABLE BOWEL SYNDROMEBeneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Biochemical Pharmacology)31 CBD FOR IRRITABLE BOWEL SYNDROMECannabinoids and the gut: New developments and emerging concepts31 CBD FOR IRRITABLE BOWEL SYNDROMEEndocannabinoids and the gastrointestinal tract31 CBD FOR IRRITABLE BOWEL SYNDROMECannabinoids and gastrointestinal motility: Animal and human studies432 CBD FOR KIDNEY DISEASECannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death32 CBD FOR KIDNEY DISEASEChronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay32 CBD FOR KIDNEY DISEASEIs There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?32 CBD FOR KIDNEY DISEASEThe emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases733 CBD FOR LIVER DISEASEThe endocannabinoid system and liver diseases33 CBD FOR LIVER DISEASECannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death33 CBD FOR LIVER DISEASECannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis33 CBD FOR LIVER DISEASETherapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats33 CBD FOR LIVER DISEASERole of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol33 CBD FOR LIVER DISEASECannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice33 CBD FOR LIVER DISEASECannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation534 CBD FOR METABOLIC SYNDROMEThe impact of marijuana use on glucose, insulin, and insulin resistance among US adults34 CBD FOR METABOLIC SYNDROMEThe potential use of cannabidiol in the therapy of metabolic syndrome34 CBD FOR METABOLIC SYNDROMECannabinoids and endocannabinoids in metabolic disorders with focus on diabetes34 CBD FOR METABOLIC SYNDROMEMetabolic syndrome in people with a psychotic illness: is cannabis protective?34 CBD FOR METABOLIC SYNDROMECannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome535 CBD FOR MIGRAINESClinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?35 CBD FOR MIGRAINESEffects of anandamide in migraine: data from an animal model35 CBD FOR MIGRAINESCannabinoids and hallucinogens for headache35 CBD FOR MIGRAINESThe endocannabinoid system and migraine35 CBD FOR MIGRAINESVariations in the cannabinoid receptor 1 gene predispose to migraine636 CBD FOR MOOD DISORDERSMultiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders36 CBD FOR MOOD DISORDERSThe endocannabinoid system and the treatment of mood and anxiety disorders36 CBD FOR MOOD DISORDERSThe endocannabinoid system and psychiatric disorders36 CBD FOR MOOD DISORDERSThe endocannabinoid system in the regulation of emotions throughout lifespan: A discussion on therapeutic perspectives36 CBD FOR MOOD DISORDERSEndocannabinoid system dysfunction in mood and related disorders36 CBD FOR MOOD DISORDERSEffects of cannabidiol ( CBD) on regional cerebral blood flow337 CBD FOR MOTION SICKNESSMotion sickness, stress and the endocannabinoid system37 CBD FOR MOTION SICKNESSDexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system37 CBD FOR MOTION SICKNESSThe Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis1038 CBD FOR MULTIPLE SCLEROSISSativex for the management of multiple sclerosis symptoms38 CBD FOR MULTIPLE SCLEROSISTHC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis38 CBD FOR MULTIPLE SCLEROSISClinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity38 CBD FOR MULTIPLE SCLEROSISCannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors38 CBD FOR MULTIPLE SCLEROSISOromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial38 CBD FOR MULTIPLE SCLEROSISNabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis38 CBD FOR MULTIPLE SCLEROSISSativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis38 CBD FOR MULTIPLE SCLEROSISA double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis38 CBD FOR MULTIPLE SCLEROSISMeta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain(38 CBD FOR MULTIPLE SCLEROSISSativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain639 CBD FOR NAUSEACannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus39 CBD FOR NAUSEACannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation39 CBD FOR NAUSEAInteraction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol ( CBD) in rats and shrews39 CBD FOR NAUSEARegulation of nausea and vomiting by cannabinoids39 CBD FOR NAUSEACannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats39 CBD FOR NAUSEAPreliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting540 CBD FOR NEURODEGENERATIONCannabidiol: A promising drug for neurodegenerative disorders?40 CBD FOR NEURODEGENERATIONCannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?40 CBD FOR NEURODEGENERATIONTransdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder40 CBD FOR NEURODEGENERATIONMemory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders40 CBD FOR NEURODEGENERATIONCannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection1841 CBD FOR NEUROPATHIC PAINMeta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain41 CBD FOR NEUROPATHIC PAINSativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain41 CBD FOR NEUROPATHIC PAIN Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine41 CBD FOR NEUROPATHIC PAINSativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial41 CBD FOR NEUROPATHIC PAINCannabinoids for neuropathic pain41 CBD FOR NEUROPATHIC PAINNeuropathic orofacial pain: Cannabinoids as a therapeutic avenue41 CBD FOR NEUROPATHIC PAINOromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial41 CBD FOR NEUROPATHIC PAINThe non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain41 CBD FOR NEUROPATHIC PAINVanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation41 CBD FOR NEUROPATHIC PAINCannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy41 CBD FOR NEUROPATHIC PAINAntihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: Mechanisms involved41 CBD FOR NEUROPATHIC PAINNon-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action41 CBD FOR NEUROPATHIC PAINCannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors41 CBD FOR NEUROPATHIC PAINRole of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes41 CBD FOR NEUROPATHIC PAINCannabinoids in the management of difficult to treat pain41 CBD FOR NEUROPATHIC PAINMulticenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain41 CBD FOR NEUROPATHIC PAIN Marijuana extract helps prevent chemo pain41 CBD FOR NEUROPATHIC PAINPot users less likely to take painkillers642 CBD FOR OBESITYThe impact of marijuana use on glucose, insulin, and insulin resistance among US adults42 CBD FOR OBESITYCannabinol and cannabidiol exert opposing effects on rat feeding patterns42 CBD FOR OBESITY Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?42 CBD FOR OBESITYThe endocannabinoid system in obesity and type 2 diabetes42 CBD FOR OBESITYRole of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk42 CBD FOR OBESITYCannabinoids and endocannabinoids in metabolic disorders with focus on diabetes343 CBD FOR OCDPlasma and brain pharmacokinetic profile of cannabidiol ( CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour (PubMed)43 CBD FOR OCDPlasma and brain pharmacokinetic profile of cannabidiol ( CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour43 CBD FOR OCDInvolvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice744 CBD FOR PARKINSONS DISEASEEffects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial44 CBD FOR PARKINSONS DISEASEProspects for cannabinoid therapies in basal ganglia disorders44 CBD FOR PARKINSONS DISEASEEvaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties44 CBD FOR PARKINSONS DISEASECannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease44 CBD FOR PARKINSONS DISEASECannabidiol for the treatment of psychosis in Parkinson’s disease44 CBD FOR PARKINSONS DISEASESymptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease44 CBD FOR PARKINSONS DISEASETherapeutic potential of cannabinoids in CNS disease345 CBD FOR PRIONNonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity45 CBD FOR PRIONCannabidiol: A prion therapy for mice?45 CBD FOR PRIONAlteration of the endocannabinoid system in mouse brain during prion disease1346 CBD FOR PTSDThe endocannabinoid system provides an avenue for evidence-based treatment development for PTSD46 CBD FOR PTSDReductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks46 CBD FOR PTSDEnhancing cannabinoid neurotransmission augments the extinction of conditioned fear46 CBD FOR PTSDCannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors46 CBD FOR PTSDStress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis46 CBD FOR PTSDMitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence46 CBD FOR PTSDCannabinoid modulation of fear extinction brain circuits: A novel target to advance anxiety treatment46 CBD FOR PTSDThe endocannabinoid system and extinction learning46 CBD FOR PTSDA current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers46 CBD FOR PTSDCannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit46 CBD FOR PTSDNon-antidepressant long-term treatment in post-traumatic stress disorder46 CBD FOR PTSDThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system46 CBD FOR PTSDModulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors447 CBD FOR RHEUMATISMCannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress47 CBD FOR RHEUMATISMEfficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases47 CBD FOR RHEUMATISMClinical Implications for Cannabinoid Use in the Rheumatic Diseases47 CBD FOR RHEUMATISMCannabinoids in the Management of Musculoskeletal or Rheumatic Diseases1248 CBD FOR SCHIZOPHRENIACannabidiol, a Cannabis sativa constituent, as an antipsychotic drug48 CBD FOR SCHIZOPHRENIACannabidiol as a potential treatment for psychosis48 CBD FOR SCHIZOPHRENIACannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia48 CBD FOR SCHIZOPHRENIAMedical use of cannabis. Cannabidiol: A new light for schizophrenia?48 CBD FOR SCHIZOPHRENIAA critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation48 CBD FOR SCHIZOPHRENIAPeripheral endocannabinoid system dysregulation in first-episode psychosis48 CBD FOR SCHIZOPHRENIACannabinoids and schizophrenia: Therapeutic prospects48 CBD FOR SCHIZOPHRENIAAntipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies48 CBD FOR SCHIZOPHRENIACannabidiol monotherapy for treatment-resistant schizophrenia48 CBD FOR SCHIZOPHRENIA Cannabis with high cannabidiol content is associated with fewer psychotic experiences48 CBD FOR SCHIZOPHRENIA Marijuana compound treats schizophrenia with few side effects: Clinical trial48 CBD FOR SCHIZOPHRENIAClearing the smoke: what do we know about adolescent cannabis use and schizophrenia?349 CBD FOR SICKLE CELL ANEMIAPain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: Modulation by cannabinoids49 CBD FOR SICKLE CELL ANEMIA Cannabis use in sickle cell disease: A questionnaire study49 CBD FOR SICKLE CELL ANEMIACannabinoid Receptor-Specific Mechanisms To Alleviate Pain In Sickle Cell Anemia Via Inhibition Of Mast Cell Activation And Neurogenic Inflammation850 CBD FOR SKIN CONDITIONSCannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis50 CBD FOR SKIN CONDITIONSCannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes50 CBD FOR SKIN CONDITIONSThe endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities50 CBD FOR SKIN CONDITIONSEpigenetic control of skin differentiation genes by phytocannabinoids50 CBD FOR SKIN CONDITIONSEndocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-150 CBD FOR SKIN CONDITIONSCannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation50 CBD FOR SKIN CONDITIONSAttenuation of allergic contact dermatitis through the endocannabinoid system50 CBD FOR SKIN CONDITIONSTopical cannabinoid agonists. An effective new possibility for treating chronic pruritus751 CBD FOR SLEEP DISORDERSThe nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent51 CBD FOR SLEEP DISORDERS Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine51 CBD FOR SLEEP DISORDERSEffects of acute systemic administration of cannabidiol on sleep-wake cycle in rats51 CBD FOR SLEEP DISORDERSEffect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults51 CBD FOR SLEEP DISORDERSCannabidiol, a constituent of Cannabis sativa, modulates sleep in rats51 CBD FOR SLEEP DISORDERSEndocannabinoid modulation of cortical up-states and NREM sleep51 CBD FOR SLEEP DISORDERSIntranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat452 CBD FOR SPINAL CORD INJURYCannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury52 CBD FOR SPINAL CORD INJURY Cannabis effect on spasticity in spinal cord injury52 CBD FOR SPINAL CORD INJURYAn Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease52 CBD FOR SPINAL CORD INJURYModulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury1353 CBD FOR STRESSEndogenous cannabinoid signaling is essential for stress adaptation53 CBD FOR STRESSRegulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders53 CBD FOR STRESSFunctional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output53 CBD FOR STRESSNeuromodulators, stress and plasticity: a role for endocannabinoid signalling53 CBD FOR STRESSDownregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress53 CBD FOR STRESSEndocannabinoids and stress53 CBD FOR STRESSStress regulates endocannabinoid-CB1 receptor signaling53 CBD FOR STRESSChronic Stress Impairs α1-Adrenoceptor-Induced Endocannabinoid-Dependent Synaptic Plasticity in the Dorsal Raphe Nucleus53 CBD FOR STRESSEndocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance53 CBD FOR STRESSCannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression53 CBD FOR STRESSCannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory53 CBD FOR STRESSThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system53 CBD FOR STRESSLow-frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid654 CBD FOR STROKE/TBICannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury54 CBD FOR STROKE/TBICannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism54 CBD FOR STROKE/TBICannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism (54 CBD FOR STROKE/TBICannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function54 CBD FOR STROKE/TBIProtective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice54 CBD FOR STROKE/TBIRepeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance

[ad_2]